This topic contains a solution. Click here to go to the answer

Author Question: Which one of the following statements best describes the purpose of obtaining a single Glasgow Coma ... (Read 119 times)

future617RT

  • Hero Member
  • *****
  • Posts: 543
Which one of the following statements best describes the purpose of obtaining a single Glasgow Coma Scale score (GCS) in a patient with a head injury?
 
  a. The score gives information about the type of injury to the brain.
  b. The score provides an objective measure of the patient's overall neurologic condition.
  c. The score is important in guiding an OEC Technician's treatment of the patient.
  d. The score helps determine whether a patient's mental status is improving or deteriorating.

Question 2

An OEC Technician should obtain the medical history of an alert and oriented trauma patient during the:
 
  a. primary assessment.
  b. scene size-up.
  c. secondary assessment.
  d. reassessment.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jsm54321

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

Answer: b

Answer to Question 2

Answer: c





 

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library